Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Nektar Therapeutics
13G/A
NKTR · 640268306
|
9.8% |
9/28/2026
Event 9/25/2026
|
|||
| Two Seas Capital LP | 9.8% | ||||
| Two Seas Capital GP LLC | 9.8% | ||||
| Sina Toussi | 9.8% | ||||
|
Sable Offshore Corp.
13G
SOC · 78574H104
|
5.4% |
8/14/2026
Event 6/30/2026
|
|||
| Two Seas Capital LP | 5.4% | ||||
| Two Seas Capital GP LLC | 5.4% | ||||
| Sina Toussi | 5.4% | ||||
|
Calumet, Inc.
13G/A
CLMT · 131428104
|
7.5% |
8/14/2026
Event 6/30/2026
|
|||
| Two Seas Capital LP | 7.5% | ||||
| Two Seas Capital GP LLC | 7.5% | ||||
| Sina Toussi | 7.5% | ||||
|
Quantum Corporation
13G
QMCO · 747906600
|
6.3% |
8/14/2026
Event 6/30/2026
|
|||
| Two Seas Capital LP | 6.3% | ||||
| Two Seas Capital GP LLC | 6.3% | ||||
| Sina Toussi | 6.3% | ||||
|
PAVmed Inc.
13G
PAVM · 70387R502
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Two Seas Capital LP | 10.0% | ||||
| Two Seas Capital GP LLC | 10.0% | ||||
| Sina Toussi | 10.0% | ||||
|
Veradigm Inc.
13G/A
MDRX · 01988P108
|
8.2% |
5/15/2026
Event 3/31/2026
|
|||
| Two Seas Capital LP | 8.2% | ||||
| Two Seas Capital GP LLC | 8.2% | ||||
| Sina Toussi | 8.2% | ||||
|
Arbutus Biopharma Corporation
13G/A
ABUS · 03879J100
|
9.4% |
5/15/2026
Event 3/31/2026
|
|||
| Two Seas Capital LP | 9.4% | ||||
| Two Seas Capital GP LLC | 9.4% | ||||
| Sina Toussi | 9.4% | ||||
|
Core Scientific, Inc.
13D/A
CORZ · 21874A106
|
4.4% |
4/23/2026
Event 4/23/2026
|
|||
| Two Seas Capital LP | 4.4% | ||||
| Two Seas Capital GP LLC | 4.4% | ||||
| Sina Toussi | 4.4% | ||||
|
Odyssey Marine Exploration Inc
13D
OMEX · 676118201
|
10.0% |
4/13/2026
Event 4/8/2026
|
|||
| Two Seas Capital LP | 10.0% | ||||
| Two Seas Capital GP LLC | 10.0% | ||||
| Sina Toussi | 10.0% | ||||
|
Avadel Pharmaceuticals PLC
13G/A
AVDL · G29687103
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Two Seas Capital LP | 0% | ||||
| Two Seas Capital GP LLC | 0% | ||||
| Sina Toussi | 0% | ||||
|
Indivior PLC
13D/A
INDV · G4766E116
|
4.98% |
12/23/2025
Event 12/23/2025
|
|||
| Two Seas Capital LP | 4.98% | ||||
| Two Seas Capital GP LLC | 4.98% | ||||
| Sina Toussi | 4.98% | ||||
|
Esperion Therapeutics, Inc.
13G/A
ESPR · 29664W105
|
4.7% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 4.7% | ||||
| Two Seas Capital GP LLC | 4.7% | ||||
| Sina Toussi | 4.7% | ||||
|
Adaptimmune Therapeutics PLC
13G/A
ADAPY · 00653A107
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 0% | ||||
| Two Seas Capital GP LLC | 0% | ||||
| Sina Toussi | 0% | ||||
|
Gannett Co., Inc.
13G/A
TDAY · 36472T109
|
9.6% |
11/14/2025
Event 9/30/2025
|
|||
| Two Seas Capital LP | 9.6% | ||||
| Two Seas Capital GP LLC | 9.6% | ||||
| Sina Toussi | 9.6% | ||||
|
Core Scientific, Inc.
13D
CORZ · 21874A106
|
6.3% |
8/8/2025
Event 8/7/2025
|
|||
| Two Seas Capital LP | 6.3% | ||||
| Two Seas Capital GP LLC | 6.3% | ||||
| Sina Toussi | 6.3% | ||||